Antiverse and GlobalBio, Inc. extend collaboration to advance antibody cancer therapeutics
Antiverse Ltd (Antiverse), a biotechnology company developing a computational antibody drug discovery platform, and GlobalBio, Inc. (GlobalBio), an antibody engineering company developing methods to engineer improved and more developable therapeutic antibodies, today announced they...
Move over carbon, the nanotube family just got bigger
Tokyo, Japan – Researchers from Tokyo Metropolitan University have engineered a range of new single-walled transition metal dichalcogenide (TMD) nanotubes with different compositions, chirality, and diameters by templating off boron-nitride nanotubes. They also realized...
£800,000 grant to boost the development of bacteriophages to combat disease
Pioneering work to develop effective and safe bacteriophages to combat disease has received an £800,000 boost. The grant from the Biotechnology and Biological Sciences Research Council (BBSRC), is aimed at advancing the production of...
Nongenetic mechanisms play a role in lung cancer treatment resistance
FINDINGSIn a recent study led by Ravi Salgia, M.D., Ph.D., the Arthur & Rosalie Kaplan Chair in Medical Oncology, a team of researchers from City of Hope, one of the largest cancer research and...
PET imaging validates use of common cholesterol drug to enhance HER2-targeted cancer therapy
Reston, VA—A novel therapeutic approach that combines human epidermal growth receptor factor 2 (HER2)-targeted therapies with the cholesterol-lowering drug lovastatin can reduce the number of cancer treatments required to prevent tumor growth. Monitored by...
On top again: UTA wins national award for noise control engineering
For the fourth time in five years, students at The University of Texas at Arlington have won a prestigious national award for noise control engineering.
Credit: UT Arlington
For the fourth time in five years, students...
Moderna’s updated COVID-19 vaccine for Autumn 2023 outperforms in cost and clinical impact
In a recent study posted to medRxiv preprint* server, researchers at pharmaceutical and biotechnology company Moderna, Inc. estimated the economic and clinical impact of updated messenger ribonucleic acid (mRNA) vaccines for coronavirus disease 2019...
Landmark publication calls for increased attention to workplace mental health
A landmark scientific article on the workplace as a major determinant of health is published today (Thursday, 12 October) in The Lancet, and reveals a global picture of the work-related causes of mental health...
Accelerating mRNA-LNP Formulation Screening for Genomic Drug Discovery and Development
REGISTER NOW
Panelists:
Arpan DesaiManaging DirectorNanoVation Therapeutics UK
Graham Hayes, PhDSenior ScientistNanoVation Therapeutics UK
Ben Knappett, PhDProduct Manager, LNP SolutionsUnchained Labs
Broadcast Date: November 8, 2023Time: 8:00 am PT, 11:00 am ET, 17:00...
Ensuring raw material quality in drug production and manufacturing
insights from industrySuja Sukamaran, Sudhir Dahal, Eden Couillard, Mike GarryFTIR Product Manager, Raman Product Manager, Applications Scientist, NIR Product ManagerThermo Fisher Scientific In this interview, Thermo Fisher Scientific discusses how to ensure the...
